What is the safest way to prescribe emergency contraception?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 4, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Emergency Contraception: Evidence-Based Prescribing Approach

The safest and most effective approach to prescribing emergency contraception is to offer the copper IUD as first-line when feasible, or ulipristal acetate (30 mg) as the preferred oral option, particularly when presenting 72-120 hours after intercourse or in women who are overweight/obese. 1

Hierarchy of Effectiveness

The CDC and WHO guidelines establish a clear efficacy ranking for emergency contraception methods 1:

  • Copper IUD: Most effective option, can be inserted within 5 days of unprotected intercourse (or up to 5 days after ovulation if timing can be estimated) 1
  • Ulipristal acetate (UPA): 30 mg single dose, effective up to 120 hours 1, 2
  • Levonorgestrel (LNG): 1.5 mg single dose or 0.75 mg twice (12 hours apart), effective up to 120 hours but declining efficacy after 72 hours 1
  • Combined estrogen-progestin (Yuzpe): Least effective and most side effects; not recommended 1

Timing-Based Selection Algorithm

Within 0-72 Hours of Intercourse

  • UPA and levonorgestrel have similar effectiveness when taken within the first 3 days, though UPA shows superior pregnancy prevention (1.4% vs 2.2%, P=0.046) 1, 3
  • UPA is significantly more effective in the first 24 hours (0.9% pregnancy rate vs 2.5% with LNG, P=0.035) 3
  • Either option is acceptable, but UPA may be preferred for maximum efficacy 1, 2

Between 72-120 Hours of Intercourse

  • UPA is definitively superior to levonorgestrel in this window, with 0 pregnancies versus 3 pregnancies with LNG (P=0.037) 1, 3
  • UPA maintains consistent efficacy throughout the 120-hour window without significant decline (P=0.44), with pregnancy rates of 2.3% at 48-72 hours, 2.1% at 72-96 hours, and 1.3% at 96-120 hours 4, 3
  • Levonorgestrel efficacy decreases significantly after 72 hours 1

Patient-Specific Considerations

Overweight and Obese Women

Ulipristal acetate is more effective than levonorgestrel in women who are overweight or obese 1, 2. This is a critical consideration given that levonorgestrel may have reduced effectiveness in this population 1.

Breastfeeding Women

  • Both UPA and levonorgestrel can be used, though small amounts pass into breast milk 4
  • The copper IUD has no hormonal concerns for breastfeeding 1

Administration Instructions

Ulipristal Acetate Protocol

  • Single 30 mg dose taken as soon as possible within 120 hours 1, 2, 4
  • Can be taken with or without food 4
  • If vomiting occurs within 3 hours, contact provider immediately for possible repeat dose 4
  • Critical timing restriction: After taking UPA, wait 5 days before starting or resuming hormonal contraception 2, 4
  • Use barrier contraception for 14 days or until next menses after UPA use 1, 2
  • Do not use additional levonorgestrel emergency contraception within 5 days of UPA 4

Levonorgestrel Protocol

  • Single 1.5 mg dose (preferred) or two 0.75 mg doses 12 hours apart 1
  • The second dose can be taken 12-24 hours after the first without compromising efficacy 5
  • Can start regular contraception immediately after use 1
  • Use barrier method for 7 days when resuming hormonal contraception 1

Copper IUD Protocol

  • Insert within 5 days of unprotected intercourse 1
  • Provides immediate ongoing contraception 1
  • Most effective emergency contraception method overall 1

Advance Provision Strategy

The CDC supports providing advance supplies of emergency contraceptive pills so women have immediate access when needed 1. Evidence shows advance provision increases use 2-7 fold without affecting regular contraceptive patterns or STI rates 1.

Critical Safety Monitoring

  • Pregnancy test recommended if withdrawal bleeding does not occur within 3 weeks after taking emergency contraception 2
  • Seek immediate evaluation for severe lower abdominal pain 3-5 weeks after use to rule out ectopic pregnancy 4
  • Menses may occur earlier or later than expected by several days; delay >1 week warrants pregnancy evaluation 4

Common Pitfalls to Avoid

  • Do not delay administration: Efficacy decreases with time for all methods 1
  • Do not use UPA more than once per menstrual cycle 4
  • Do not start hormonal contraception immediately after UPA—this is a unique requirement compared to levonorgestrel and requires a 5-day waiting period 2, 4
  • Do not assume levonorgestrel and UPA are interchangeable—they have different mechanisms, timing windows, and post-administration contraceptive protocols 1, 2
  • Emergency contraception does not protect against sexually transmitted infections 4

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Effects of Ulipristal Acetate as an Emergency Contraceptive

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.